HealthEquity, Inc. provided earning guidance for the fiscal year ending January 31, 2023. For the period, The company expects revenues of $820 million to $830 million. Its outlook for net loss is between $61 million and $53 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
86.2 USD | +2.25% |
|
+3.06% | +30.02% |
06-26 | Healthequity Insider Sold Shares Worth $4,578,579, According to a Recent SEC Filing | MT |
06-20 | Wells Fargo Raises Price Target on HealthEquity to $110 From $107, Maintains Overweight Rating | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+30.02% | 7.33B | |
+18.86% | 3,366B | |
+15.57% | 91.16B | |
+12.99% | 84.42B | |
+47.52% | 56.16B | |
-20.20% | 49.25B | |
+35.77% | 48.04B | |
-25.64% | 45.03B | |
+76.35% | 42.79B | |
-3.39% | 27.47B |
- Stock Market
- Equities
- HQY Stock
- News HealthEquity, Inc.
- Healthequity, Inc. Provides Earnings Guidance for the Fiscal Year Ending January 31, 2023